-
1
المؤلفون: Emma Francis, John A. Anderson, Emmanuel Danso, William Devries, Tanner Robl, Nicholas Kettelkamp, Jacob Cushing, Loren D. Berenbom, Raghuveer Dendi, Martin Emert, Amit Noheria, Rhea Pimentel, Rigoberto Ramirez, Madhu Reddy, Seth H. Sheldon
المصدر: Heart Rhythm. 20:S369-S370
مصطلحات موضوعية: Physiology (medical), Cardiology and Cardiovascular Medicine
-
2
المؤلفون: Alexander Robinson, Valay Parikh, Mohammad‐Ali Jazayeri, Michael Pierpoline, Y. Madhu Reddy, Martin Emert, Rhea Pimentel, Raghuveer Dendi, Loren Berenbom, Amit Noheria, Rigoberto Ramirez, Andrew J. Sauer, Zubair Shah, Travis Abicht, Nicholas Haglund, Seth H. Sheldon
المصدر: Pacing and Clinical Electrophysiology. 45:204-211
مصطلحات موضوعية: Male, Primary Prevention, Tachycardia, Ventricular, Humans, Female, Heart-Assist Devices, General Medicine, Middle Aged, Cardiology and Cardiovascular Medicine, Defibrillators, Implantable, Retrospective Studies
الوصف: Patients with left ventricular assist devices (LVAD) often tolerate ventricular arrhythmias (VA). We aim to assess the frequency and outcomes of ICD therapies averted by ultraconservative ICD programming (UCP) in LVAD patients.This single center, retrospective cohort study included patients with LVADs and ICDs implanted from 2015 to 2019 that had UCP. The aim for UCP was to maximally delay VA treatments and maximize anti-tachycardia pacing (ATP) prior to ICD shocks. VA events were reviewed after UCP and evaluated under prior conservative programming to assess for potentially averted events (that would have resulted in either ATP or defibrillation with prior programming).Fifty patients were included in the study with follow-up of median 16 ± 10.2 months after UCP. The median time from LVAD implantation to reprogramming was 7 days (IQR 5-9 days). Fourteen patients (28%) had potentially averted VA events that would have been treated with their prior ICD programming (82 total events, median two events per patient, IQR 1-10 events). Treated VA events occurred in 15 patients (30%). Eleven of the 14 patients with potentially averted VAs had treated events as well. Only one patient reported definitive symptoms of self-limited "dizziness" during a potentially averted event that did not result in hospitalization. No patients died of complications from or needed emergent care/hospitalization due a potentially averted VA.UCP in LVAD patients likely prevented unnecessary VA treatments in many patients with minimal reported symptoms during these potentially averted events. Prospective studies are necessary to confirm these findings.
-
3PO-04-142 IMPACT OF PERSISTENT LEFT SUPERIOR VENA CAVA ON OUTCOMES WITH ATRIAL FIBRILLATION ABLATION
المؤلفون: Claire Sorensen, Jinxiang Hu, Raghuveer Dendi, Martin Emert, Amit Noheria, Rhea Pimentel, Rigoberto Ramirez, Madhu Reddy, Seth H. Sheldon
المصدر: Heart Rhythm. 20:S599
مصطلحات موضوعية: Physiology (medical), Cardiology and Cardiovascular Medicine
-
4
المؤلفون: Antonio Porfilio, Martin Emert, Keith Holloman, Suneet Mittal, Abdul R. Maher, John Schoenhard, Mintu P. Turakhia, Naushad A. Shaik, Hanscy Seide, Niraj Varma, Ana C. Natera, Paul R. Roberts, Sherry L. Di Jorio, Giuseppe Augello, Baerbel Maus, Nilam Patel, Khaldoun G. Tarakji, Ashish Patwala, Samuel F. Sears, Giulio Molon, Steven L. Zweibel, Josh R. Silverstein, Amir Zaidi, James Allred
المصدر: Heart Rhythm O2
مصطلحات موضوعية: medicine.medical_specialty, Telemedicine, Smart devices, business.industry, medicine.medical_treatment, Smart device, Cardiac resynchronization therapy, Patient engagement, Device type, law.invention, Pacemaker, Bluetooth, Clinical, Remote monitoring, law, Emergency medicine, Devices, medicine, business, Digital health
الوصف: Background High adherence to remote monitoring (RM) in pacemaker (PM) patients improves outcomes; however, adherence remains suboptimal. Bluetooth low-energy (BLE) technology in newer-generation PMs enables communication directly with patient-owned smart devices using an app without a bedside console. Objective To evaluate the success rate of scheduled RM transmissions using the app compared to other RM methods. Methods The BlueSync Field Evaluation was a prospective, international cohort evaluation, measuring the success rate of scheduled RM transmissions using a BLE PM or cardiac resynchronization therapy PM coupled with the MyCareLink Heart app. App transmission success was compared to 3 historical “control” groups from the Medtronic de-identified CareLink database: (1) PM patients with manual communication using a wand with a bedside console (PM manual transmission), (2) PM patients with wireless automatic communication with the bedside console (PM wireless); (3) defibrillator patients with similar automatic communication (defibrillator wireless). Results Among 245 patients enrolled (age 64.8±15.6 years, 58.4% men), 953 transmissions were scheduled through 12 months, of which 902 (94.6%) were successfully completed. In comparison, transmission success rates were 56.3% for PM manual transmission patients, 77.0% for PM wireless patients, and 87.1% for defibrillator wireless patients. Transmission success with the app was superior across matched cohorts based on age, sex, and device type (single vs dual vs triple chamber). Conclusion The success rate of scheduled RM transmissions was higher among patients using the smart device app compared to patients using traditional RM using bedside consoles. This novel technology may improve patient engagement and adherence to RM.
Graphical abstract -
5
المؤلفون: Mejalli Al‐Kofahi, Oluwaseun G. Adeola, Jason Payne, Moghniuddin Mohammed, Y. Madhu Reddy, Raghuveer Dendi, Rhea Pimentel, Loren Berenbom, Martin Emert, Rigoberto Ramirez, Amit Noheria, Jay A. Montgomery, Seth H. Sheldon
المصدر: Pacing and clinical electrophysiology : PACEREFERENCES.
مصطلحات موضوعية: General Medicine, Cardiology and Cardiovascular Medicine
الوصف: The subcutaneous ICD (S-ICD) is a viable alternative to transvenous ICD and avoids intravascular complications in patients without a pacing indication. The outcomes of S-ICD implantation are uncertain in patients with prior sternotomy.We aim to compare the implant techniques and outcomes with S-ICD implantation in patients with and without prior sternotomy.Multicenter retrospective cohort study including adult patients with an S-ICD implanted between January 2014 and June 2020. Outcomes were compared between patients with and without prior sternotomy.Among the 212 patients (49 ± 15 years old, 43% women, BMI 30 ± 8 kg/mImplantation of an S-ICD in patients with prior sternotomy is safe with a similar risk of 30-day complications and inappropriate ICD shocks as patients without prior sternotomy.
-
6دورية أكاديمية
المؤلفون: Jayasree Pillarisetti, MD, Martin Emert, MD, Mazda Biria, MD, Rashaad Chotia, MD, Rajeshwer Guda, MBBS, Sudharani Bommana, M.Phil, Rhea Pimentel, MD, James Vacek, MD, MSc, FACC, FAHA, Raghuveer Dendi, MD, Loren Berenbom, MD, Buddhadeb Dawn, MD, FAHA, Dhanunjaya Lakkireddy, MD, FACC, FHRS
المصدر: Indian Pacing and Electrophysiology Journal, Vol 15, Iss 1, Pp 20-29 (2015)
مصطلحات موضوعية: Implantable cardioverter-defibrillator, Outcomes, sudden cardiac death, Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: Background: Despite ACC/AHA guidelines indicating implantable cardioverter defibrillator (ICD) as class I therapy for primary prevention of sudden cardiac death in patients with EF≤35%, ICD utilization rates in real world practice have been low. Objective: To determine the rate of ICD implantation at a tertiary care academic center and to assess the reasons for under-utilization of the same. Methods: Review of a prospectively collected database which included all patients diagnosed with an EF≤35% was performed to assess the rate of ICD implantation and mortality. Reasons for non-implantation of ICD were then assessed from detailed chart review. Results: A total of 707 patients (age 69.4 ± 14.1 years) with mean EF of 26±7% were analyzed. Only 28% (200/707) of patients had ICDs implanted. Mortality was lower in the group with ICD (25% vs 37%, p=0.004). When patients who either died or were lost to follow-up prior to 2005 were excluded, ICD utilization rate was still low at 37.6%. The most common reason for non-implantation of ICD was physicians not discussing this option with their patients. Patient refusal was the second most common reason. Conclusions: ICD Implantation rates for primary prevention of SCD in patients with EF≤35% is low. Physician and patient education should be addressed to improve the utilization rates.
وصف الملف: electronic resource
-
7
المؤلفون: Martin Emert, Mohammad-Ali Jazayeri
المصدر: Medical Clinics of North America. 103:913-930
مصطلحات موضوعية: congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, business.industry, Incidence (epidemiology), General Medicine, medicine.disease, Sudden cardiac death, Cardiovascular death, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Epidemiology, Medicine, Treatment strategy, cardiovascular diseases, 030212 general & internal medicine, business, Intensive care medicine, 030217 neurology & neurosurgery, Cause of death
الوصف: Sudden cardiac death (SCD) is a leading cause of death in the United States. Despite improvements in therapy, the incidence of SCD as a proportion of overall cardiovascular death remains relatively unchanged. This article aims to answer the question, "Who is at risk for SCD?" In the process, it reviews the definition, pathophysiology, epidemiology, and risk factors of SCD. Patients at risk for SCD and appropriate treatment strategies are discussed.
-
8B-PO04-049 MULTICENTER OUTCOMES WITH SUBCUTANEOUS ICD IMPLANTATION IN PATIENTS WITH PRIOR STERNOTOMY
المؤلفون: Raghuveer Dendi, Rhea Pimentel, Mejalli Al-Kofahi, Moghniuddin Mohammed, Jay A. Montgomery, Amit Noheria, Seth H. Sheldon, Jason Payne, Madhu Reddy, Martin Emert, Loren Berenbom, Oluwaseun G. Adeola, Ramirez Rigoberto
المصدر: Heart Rhythm. 18:S298-S299
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Physiology (medical), Medicine, In patient, Cardiology and Cardiovascular Medicine, business, Icd implantation, Surgery
-
9
المؤلفون: Seth H. Sheldon, Moghniuddin Mohammed, Madhu Reddy, Martin Emert, Raghuveer Dendi, Rhea Pimentel, Mejalli Al-Kofahi, Loren Berenbom, Rigoberto Ramirez, Amit Noheria
المصدر: Circulation. 142
مصطلحات موضوعية: medicine.medical_specialty, Sternum, business.industry, Physiology (medical), Medicine, In patient, Cardiology and Cardiovascular Medicine, business, Icd implantation, Surgery
الوصف: Introduction: Subcutaneous ICD (S-ICD) implantation is a viable alternative to transvenous ICD implantation in patients without a pacing indication. The S-ICD lead is placed near the sternum. The safety of S-ICD implantation and risk for inappropriate shocks is uncertain in patients with prior sternotomy. Methods: This single-center retrospective cohort study included patients that had implantation of an S-ICD between February 2014 - May 2020. The 30-day complication rates and long-term risks of inappropriate shocks were compared between patients with and without prior sternotomy. Results: Ninety-eight patients (52 ± 15 years old, 43% men, BMI 29 ± 6, 72% primary prevention, 28% ischemic cardiomyopathy, median LVEF 30% (IQR 25-45%)) underwent S-ICD implantation, among whom 19 (19.4%) had a prior sternotomy. The median time between sternotomy and S-ICD implantation was 96 (IQR 4.1-306) months. The sternal coil was primarily implanted left of the sternum (n=17/19, 89%). A two-incision technique was used in 79% of patients with prior sternotomy vs. 65% without sternotomy (p=0.23). The 30-day complication rate was similar between those with and without prior sternotomy (n=1/19 vs. n=10/79, 5% vs. 13%, p=0.36). The only 30-day complication in patients with prior sternotomy was a hematoma without intervention. The 30-day complications in patients without prior sternotomy included: superficial site infection resolving with brief antibiotics (n=4), inappropriate shock (n=3), lead migration requiring revision (n=2), and a hematoma without intervention (n=1). Over a median follow-up of 17.1 (IQR 3.4-29.1) months, the frequency of inappropriate shocks was similar between patients with and without prior sternotomy (n=1/19 and n=6/79, 5% vs. 8%, p=0.72). The median time to inappropriate shock from S-ICD implantation was 1.1 (IQR 0.1-19.8) months. The mechanisms of inappropriate shocks were T-wave oversensing or other oversensing (n=5/7, 72%), air in the pocket (n=1/7, 14%), and atrial tachycardia (n=1/7, 14%). Conclusions: Implantation of S-ICD in patients with prior sternotomy was not associated with an increased risk of 30-day complications or inappropriate shocks. These outcomes need to be confirmed in larger, multicenter studies.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::be942e5d541a869c93b8d19b6ca97f51
https://doi.org/10.1161/circ.142.suppl_3.16273 -
10
المؤلفون: Alex Courtney, Madhu Reddy, Muelhebach Gregory, Tarun Dalia, George L. Zorn, Raghuveer Dendi, Eric Hockstad, Peter Tadros, Farhad Sami, Rigoberto Ramirez, Rhea Pimentel, Sagar Ranka, Nachiket Apte, Amit Shreshta, Seth H. Sheldon, Martin Emert, Mark Wiley
المصدر: Circulation. 142
مصطلحات موضوعية: medicine.medical_specialty, Framingham Risk Score, business.industry, Physiology (medical), Internal medicine, medicine, Cardiology, In patient, Cardiology and Cardiovascular Medicine, business, Pacemaker implantation
الوصف: Introduction: The Emory risk score has been developed to predict new pacemaker implantation in patients undergoing TAVR procedures. There is limited data on assessing risk of early versus late pacemaker implantation in these patients. Hypothesis: The Emory risk score is similar for patients with both early and late pacemaker implantation in TAVR patients. Methods: A single center observational study was performed at our tertiary care center. All patients who underwent pacemaker implantation after TAVR procedures were included. Patients were categorized as early or late if they had pacemaker implantation within the same admission versus implantation post discharge. Standard statistical tests were used for analysis with two-sided p value Results: A total of 97 patients were studied between January 2017 to April 2020. The mean age was 77.5 ± 7 years and females were 41.2%. At baseline patients with early implantation of pacemakers (n=66) had a higher proportion of underlying RBBB (45.2% vs 23.3%, p=0.43), higher valve size as well as a higher incidence of valve oversizing > 146% (43.9 % vs 19.4 %, p =0.23)when compared to patients with late pacemakers(n=31). There was no difference between patient characteristics, baseline comorbidities, pre procedural ECG parameters as well as use of beta blocking agents. Late pacemaker implantations were associated with a overall lower Emory Risk score (1.06±1.41 vs 1.70±1.35, p =0.037). Conclusions: The Emory Risk score is significantly different for early and late pacemaker implantation. Further studies are needed evaluate risk of late pacemaker implantation.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::74fbca4d282f83b58ad77174252878bd
https://doi.org/10.1161/circ.142.suppl_3.16460
Full Text via ClinicalKey 
Full Text Finder